Palmitoylethanolamide is a nutraceutical ingredient that is considered to be an alternative to cannabidiol (CBD), certainly when considering the similarities in how the two compounds perform in the human body. PEA exerts its effects primarily by interacting with the endocannabinoid system, modulating inflammation and immune responses, and potentially activating receptors like PPAR-α and TRPV1, leading to anti-inflammatory and analgesic effects. It is produced naturally in the human body when cells or tissues are damaged but is also naturally occurring in foods such as soybean, eggs and peanuts.
PHA
14-21 days
1KG